Vaccination of mice with chitosan nanogel-associated recombinant NcPDI against challenge infection with Neospora caninum tachyzoites

Parasite Immunology

Volumn 33, Issue 2, 2011, Pages 81-94

  Debache, K ^a   Kropf, C ^a   Schutz C A ^b   Harwood, L J ^c   Kauper P ^d   Monney, T ^a   Rossi, N ^d   Laue, C ^d   Mccullough, K C ^c   Hemphill, A ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b EPFL   (Switzerland)

^c INSTITUTE OF VIROLOGY AND IMMUNOLOGY   (Switzerland)

^d Medipol SA   (Switzerland)

Author keywords

Nanogels; Neospora caninum; Protein disulfide isomerase; vaccination

Indexed keywords

ALGINIC ACID; CHITOSAN; CYTOKINE; MANNOSE; MESSENGER RNA; NANOPARTICLE; PROTEIN DISULFIDE ISOMERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN INFECTION; FEMALE; IMMUNE RESPONSE; MOUSE; NEOSPORA CANINUM; NONHUMAN; PARASITE LOAD; PRIORITY JOURNAL; PROTEIN EXPRESSION; TACHYZOITE; VACCINATION;

ADMINISTRATION, INTRANASAL; ANIMALS; BRAIN; CHITOSAN; COCCIDIOSIS; DISEASE MODELS, ANIMAL; DRUG CARRIERS; FEMALE; INJECTIONS, INTRAPERITONEAL; MICE; MICE, INBRED BALB C; NEOSPORA; POLYETHYLENE GLYCOLS; POLYETHYLENEIMINE; PROTEIN DISULFIDE-ISOMERASES; PROTOZOAN VACCINES; SURVIVAL ANALYSIS; VACCINATION; VACCINES, SYNTHETIC;

MUS; NEOSPORA CANINUM;

EID: 78651462891     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2010.01255.x     Document Type: Article

References (52)

1. Bjerkas I, Mohn SF & Presthus J. Unidentified cyst-forming sporozoon causing encephalomyelitis and myositis in dogs. Z Parasitenkd 1984; 70: 271-274.
2. Dubey JP, Hattel AL, Lindsay DS & Topper MJ. Neonatal Neospora caninum infection in dogs: isolation of the causative agent and experimental transmission. J Am Vet Med Assoc 1988; 193: 1259-1263.
3. Hemphill A, Vonlaufen N & Naguleswaran A. Cellular and immunological basis of the host-parasite relationship during infection with Neospora caninum. Parasitology 2006; 133: 261-278.
4. Dubey JP & Lindsay DS. A review of Neospora caninum and neosporosis. Vet Parasitol 1996; 67: 1-59.
5. Hemphill A. The host-parasite relationship in neosporosis. Adv Parasitol 1999; 43: 47-104.
6. Dubey JP, Schares G & Ortega-Mora LM. Epidemiology and control of neosporosis and Neospora caninum. Clin Microbiol Rev 2007; 20: 323-367.
7. McAllister MM, Dubey JP, Lindsay DS, Jolley WR, Wills RA & McGuire AM. Dogs are definitive hosts of Neospora caninum. Int J Parasitol 1998; 28: 1473-1478.
8. Gondim LF, McAllister MM, Pitt WC & Zemlicka DE. Coyotes (Canis latrans) are definitive hosts of Neospora caninum. Int J Parasitol 2004; 34: 159-161.
9. Reichel MP & Ellis JT. Neospora caninum- how close are we to development of an efficacious vaccine that prevents abortion in cattle? Int J Parasitol 2009; 39: 1173-1187.
10. Williams DJ, Guy CS, Smith RF, et al. Immunization of cattle with live tachyzoites of Neospora caninum confers protection against fetal death. Infect Immun 2007; 75: 1343-1348.
11. Ellis J, Miller C, Quinn H, Ryce C & Reichel MP. Evaluation of recombinant proteins of Neospora caninum as vaccine candidates (in a mouse model). Vaccine 2008; 26: 5989-5996.
12. Williams DJ & Trees AJ. Protecting babies: vaccine strategies to prevent foetopathy in Neospora caninum-infected cattle. Parasite Immunol 2006; 28: 61-67.
13. Innes EA & Vermeulen AN. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora. Parasitology 2006; 133: S145-S168.
14. Romero JJ, Perez E & Frankena K. Effect of a killed whole Neospora caninum tachyzoite vaccine on the crude abortion rate of Costa Rican dairy cows under field conditions. Vet Parasitol 2004; 123: 149-159.
15. Naguleswaran A, Alaeddine F, Guionaud C, et al. Neospora caninum protein disulfide isomerase is involved in tachyzoite-host cell interaction. Int J Parasitol 2005; 35: 1459-1472.
16. Esposito M, Müller N & Hemphill A. Structure-activity relationships from in vitro efficacies of the thiazolide series against the intracellular apicomplexan protozoan Neospora caninum. Int J Parasitol 2007; 37: 183-190.
17. Esposito M, Moores S, Naguleswaran A, Müller J & Hemphill A. Induction of tachyzoite egress from cells infected with the protozoan Neospora caninum by nitro- and bromo-thiazolides, a class of broad-spectrum anti-parasitic drugs. Int J Parasitol 2007; 37: 1143-1152.
18. Müller J, Naguleswaran A, Müller N & Hemphill A. Neospora caninum: functional inhibition of protein disulfide isomerase by the broad-spectrum anti-parasitic drug nitazoxanide and other thiazolides. Exp Parasitol 2008; 118: 80-88.
19. Debache K, Guionaud C, Alaeddine F & Hemphill A. Intraperitoneal and intra-nasal vaccination of mice with three distinct recombinant Neospora caninum antigens results in differential effects with regard to protection against experimental challenge with Neospora caninum tachyzoites. Parasitology 2009; 137: 229-240.
20. Borges O, Borchard G, de Sousa A, Junginger HE & Cordeiro-da-Silva A. Induction of lymphocytes activated marker CD69 following exposure to chitosan and alginate biopolymers. Int J Pharm 2007; 337: 254-264.
21. Nishimura K, Nishimura S, Seo H, Nishi N, Tokura S & Azuma I. Effect of multiporous microspheres derived from chitin and partially deacetylated chitin on the activation of mouse peritoneal macrophages. Vaccine 1987; 5: 136-140.
22. Shibata Y, Foster LA, Metzger WJ & Myrvik QN. Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-D-glucosamine, in mice. Infect Immun 1997; 65: 1734-1741.
23. Babensee JE & Paranjpe A. Differential levels of dendritic cell maturation on different biomaterials used in combination products. J Biomed Mater Res A 2005; 74: 503-510.
24. O'Hagan DT & Singh M. Microparticles as vaccine adjuvants and delivery systems. Expert Rev Vaccines 2003; 2: 269-283.
25. Wu KY, Wu M, Fu ML, et al. A novel chitosan CpG nanoparticle regulates cellular and humoral immunity of mice. Biomed Environ Sci 2006; 19: 87-95.
26. Bachmann MF, Rohrer UH, Kundig TM, Bürki K, Hengartner H & Zinkernagel RM. The influence of antigen organization on B cell responsiveness. Science 1993; 262: 1448-1451.
27. Zaharoff DA, Rogers CJ, Hance KW, Schlom J & Greiner JW. Chitosan solution enhances the immunoadjuvant properties of GM-CSF. Vaccine 2007; 25: 8673-8686.
28. Baudner BC, Balland O, Giuliani MM, et al. Enhancement of protective efficacy following intranasal immunization with vaccine plus a nontoxic LTK63 mutant delivered with nanoparticles. Infect Immun 2002; 70: 4785-4790.
29. van der Lubben IM, Kersten G, Fretz MM, Beuvery C, Coos Verhoef J & Junginger HE. Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice. Vaccine 2003; 21: 1400-1408.
30. Jaganathan KS, Rao YU, Singh P, et al. Development of a single dose tetanus toxoid formulation based on polymeric microspheres: a comparative study of poly(D, L-lactic-co-glycolic acid) versus chitosan microspheres. Int J Pharm 2005; 294: 23-32.
31. Vila A, Sanchez A, Janes K, et al. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur J Pharm Biopharm 2004; 57: 123-131.
32. Baudner BC, Verhoef JC, Giuliani MM, et al. Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform. J Drug Target 2005; 13: 489-498.
33. Bacon A, Makin J, Sizer PJ, et al. Carbohydrate biopolymers enhance antibody responses to mucosally delivered vaccine antigens. Infect Immun 2000; 68: 5764-5770.
34. Read RC, Naylor SC, Potter CW, et al. Effective nasal influenza vaccine delivery using chitosan. Vaccine 2005; 23: 4367-4374.
35. Jaganathan KS & Vyas SP. Strong systemic and mucosal immune responses to surface-modified PLGA microspheres containing recombinant hepatitis B antigen administered intranasally. Vaccine 2006; 24: 4201-4211.
36. Borges O, Borchard G, Verhoef JC, de Sousa A & Junginfger HE. Preparation of coated nanoparticles for a new mucosal vaccine delivery system. Int J Pharm 2005; 299: 155-166.
37. Borges O, Cordeiro-da-Silva A, Romeijn SG, et al. Uptake studies in rat Peyer's patches, cytotoxicity and release studies of alginate coated chitosan nanoparticles for mucosal vaccination. J Control Release 2006; 114: 348-358.
38. Borges O, Tavares J, de Sousa A, Borchard G, Junginger HE & Cordeiro-da-Silva A. Evaluation of the immune response following a short oral vaccination schedule with hepatitis B antigen encapsulated into alginate-coated chitosan nanoparticles. Eur J Pharm Sci 2007; 32: 278-290.
39. Hemphill A, Gottstein B & Kaufmann H. Adhesion and invasion of bovine endothelial cells by Neospora caninum. Parasitology 1996; 112: 183-197.
40. Debache K, Guionaud C, Alaeddine F, Mevissen M & Hemphill A. Vaccination of mice with recombinant NcROP2 antigen reduces mortality and cerebral infection in mice infected with Neospora caninum tachyzoites. Int J Parasitol 2008; 38: 1455-1463.
41. Cannas A, Naguleswaran A, Müller N, Eperon S, Gottstein B & Hemphill A. Vaccination of mice against experimental Neospora caninum infection using NcSAG1- and NcSRS2-based recombinant antigens and DNA vaccines. Parasitology 2003; 126: 303-312.
42. Cannas A, Naguleswaran A, Müller N, Gottstein B & Hemphill A. Reduced cerebral infection of Neospora caninum-infected mice after vaccination with recombinant microneme protein NcMIC3 and ribi adjuvant. J Parasitol 2003; 89: 44-50.
43. Alaeddine F, Keller N, Leepin A & Hemphill A. Reduced infection and protection from clinical signs of cerebral neosporosis in C57BL/6 mice vaccinated with recombinant microneme antigen NcMIC1. J Parasitol 2005; 91: 657-665.
44. Debache K, Alaeddine F, Guionaud C, et al. Vaccination with recombinant NcROP2 combined with recombinant NcMIC1 and NcMIC3 reduces cerebral infection and vertical transmission in mice experimentally infected with Neospora caninum tachyzoites. Int J Parasitol 2009; 39: 1373-1384.
45. Srinivasan S, Müller J, Suana A & Hemphill A. Vaccination with microneme protein NcMIC4 increases mortality in mice inoculated with Neospora caninum. J Parasitol 2007; 93: 1046-1055.
46. Müller N, Vonlaufen N, Gianinazzi C, Leib SL & Hemphill A. Application of real-time fluorescent PCR for quantitative assessment of Neospora caninum infections in organotypic slice cultures of rat central nervous system tissue. J Clin Microbiol 2002; 40: 252-255.
47. Overbergh L, Valckx D, Waer M & Mathieu C. Quantification of murine cytokine mRNAs using real time quantitative reverse transcriptase PCR. Cytokine 1999; 11: 305-312.
48. R Development Core Team. R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. 2009; Available from:.
49. Nishikawa Y, Zhang H, Huang P, Zhang G & Xuan X. Effects of a transferring antibody against Neospora caninum infection in a murine model. Vet Parasitol 2009; 160: 60-65.
50. Klevar S, Kulberg S, Boysen P, et al. Natural killer cells act as early responders in an experimental infection with Neospora caninum in calves. Int J Parasitol 2007; 37: 329-339.
51. Ramamoorthy S, Sanakkayala N, Vemulapalli R, et al. Prevention of vertical transmission of Neospora caninum in C57BL/6 mice vaccinated with Brucella abortus strain RB51 expressing N. caninum protective antigens. Int J Parasitol 2007; 37: 1531-1538.
52. Haldorson GJ, Mathison BA, Wenberg K, et al. Immunization with native surface protein NcSRS2 induces a Th2 immune response and reduces congenital Neospora caninum transmission in mice. Int J Parasitol 2005; 35: 1407-1415.